Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

NCT00143247 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

173

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Diabetes Mellitus

Interventions

DRUG: Exubera® (inhaled insulin)

Sponsor

Pfizer